LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
SK-BR-3 Brivanib
1.11
uM
LJP5
 72
hr
 1476 3169 3694 0.8581 0.7635
SK-BR-3 Brivanib
3.33
uM
LJP5
 72
hr
 1476 3159 3694 0.8552 0.7587
SK-BR-3 Brivanib
0.37
uM
LJP5
 72
hr
 1476 3015 3694 0.8164 0.6941
BT-20 Brivanib
0.37
uM
LJP5
 72
hr
 1657 5313 5505 0.9651 0.9501
MCF 10A Buparlisib
0.04
uM
LJP5
 72
hr
 513 10062 10401 0.9675 0.9658
MCF7 Buparlisib
0.04
uM
LJP5
 72
hr
 1235 3877 4156 0.9330 0.9047
MCF7 Buparlisib
10.0
uM
LJP5
 72
hr
 1235 873 4156 0.2102 -0.1238
MDA-MB-231 Buparlisib
3.33
uM
LJP5
 72
hr
 868 1135 3486 0.3257 0.1021
BT-20 Buparlisib
3.33
uM
LJP5
 72
hr
 1657 1133 5505 0.2059 -0.1362
BT-20 Buparlisib
0.04
uM
LJP5
 72
hr
 1657 5689 5505 1.0334 1.0477
MCF 10A Buparlisib
0.37
uM
LJP5
 72
hr
 513 5559 10401 0.5345 0.5104
MDA-MB-231 Buparlisib
0.04
uM
LJP5
 72
hr
 868 3829 3486 1.0985 1.1311
Hs 578T Buparlisib
10.0
uM
LJP5
 72
hr
 929 657 3228 0.2036 -0.1183
Hs 578T Buparlisib
0.37
uM
LJP5
 72
hr
 929 2477 3228 0.7675 0.6736
MDA-MB-231 Buparlisib
0.12
uM
LJP5
 72
hr
 868 3425 3486 0.9826 0.9768
Hs 578T Buparlisib
0.04
uM
LJP5
 72
hr
 929 3189 3228 0.9881 0.9833
Hs 578T Buparlisib
1.11
uM
LJP5
 72
hr
 929 1390 3228 0.4308 0.2007
MCF 10A Buparlisib
0.12
uM
LJP5
 72
hr
 513 8404 10401 0.8080 0.7981
SK-BR-3 Buparlisib
0.12
uM
LJP5
 72
hr
 1476 3057 3694 0.8276 0.7127
MCF7 Buparlisib
0.37
uM
LJP5
 72
hr
 1235 1528 4156 0.3678 0.1004
MCF7 Buparlisib
3.33
uM
LJP5
 72
hr
 1235 854 4156 0.2056 -0.1304
MCF7 Buparlisib
1.11
uM
LJP5
 72
hr
 1235 935 4156 0.2251 -0.1026
BT-20 Buparlisib
1.11
uM
LJP5
 72
hr
 1657 1787 5505 0.3246 0.0336
Hs 578T Buparlisib
3.33
uM
LJP5
 72
hr
 929 761 3228 0.2359 -0.0730
MCF 10A Buparlisib
3.33
uM
LJP5
 72
hr
 513 386 10401 0.0371 -0.0129